Skip to contentB
Biomerica Inc
B
BMRABiomerica Inc Q2 2025 · 10-Q
Revenue$1.64M$1.64M+4.4% vs Q2 2024 Net Income-$950.00K-$950.00KN/M vs Q2 2024 EPS Diluted-$0.06-$0.06N/M vs Q2 2024 Gross Profit$437,000+34.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR
Operating Cash Flowderived-$791,000N/M Margins · derivedGross margin26.7%+6.0 pt vs Q2 2024
Operating margin-60.7%+41.9 pt vs Q2 2024
Net margin-58.1%+38.1 pt vs Q2 2024
ended Nov 30, 2024 · filed Jan 14, 2025 · 45 d after period end